하이브리드 PET-MRI 시스템 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026년-2033년)

Hybrid PET MRI Systems Market Summary

The global hybrid PET MRI systems market size was valued at USD 473.9 million in 2025 and is projected to grow from USD 485.8 million in 2026 to USD 599.4 million by 2033, at a CAGR of 3.0% from 2026 to 2033. North America dominated the market, accounting for the revenue share of 41.3% in 2025. The industry is experiencing strong growth, driven by the increasing adoption of advanced multimodal imaging technologies, rising demand for precise and early disease diagnosis, and growing applications in oncology, neurology, and cardiology.

Hybrid PET/MRI (positron emission tomography/magnetic resonance imaging) systems combine simultaneous functional and anatomical imaging in a single examination, a capability the FDA classifies as a Class II medical device under 21 CFR 892.1200, product code OUO. Since the first U.S. clearance in 2011, fourteen PET/MR systems have received FDA 510(k) clearance, spanning four manufacturers. Over the same period, federal health agencies have tracked a growing burden of the two disease categories. PET/MR is most often used to evaluate cancer and neurodegenerative disease, while CMS has progressively simplified Medicare's coverage rules for PET-based diagnosis.

The National Cancer Institute's SEER Program, the U.S. government's authoritative source for population-based cancer statistics, projected 2,041,910 new cancer cases and 618,120 cancer deaths in the United States in 2025 across all sites. Within that total, several specific cancer types carry particular relevance to PET/MR: brain and other nervous-system cancers, where SEER projected 24,820 new cases and 18,330 deaths in 2025, with 187,162 Americans living with a brain or CNS cancer diagnosis as of 2022; and the two most commonly diagnosed solid tumors, female breast cancer (316,950 new cases, 42,170 deaths) and prostate cancer (313,780 new cases, 35,770 deaths) in 2025. PET/MR's ability to fuse metabolic activity with high-resolution soft-tissue anatomy is particularly suited to brain tumor delineation and to monitoring treatment response in cancers where sequential PET and MRI exams were previously required.

On the neurology side, CDC's National Center for Health Statistics recorded Alzheimer's disease as the sixth-leading cause of death in the United States across all ages in 2023, with 114,034 recorded deaths, a burden that continues to grow as the U.S. population ages. Emerging Alzheimer's drug therapies increasingly rely on PET imaging to confirm diagnosis before treatment and on MR imaging to monitor for treatment-related side effects. A combination hybrid PET/MR performs in a single simultaneous session rather than two separate appointments.

Because the FDA's 510(k) database records the applicant on every clearance, it is possible to build a complete, non-proprietary picture of which companies have brought hybrid PET/MR systems to the U.S. market and how often.

Siemens Healthineers (filing under both Siemens Medical Solutions U.S. and, most recently, Siemens Healthineers AG) holds six of the fourteen clearances on record, the most of any applicant. Its clearance history begins with the Biograph mMR (K103429, 2011) and continues through several hardware and software updates to that platform (K133226 in 2013, K163234 in 2017, K172531 in 2017, K200213 in 2020) before culminating in the Biograph One (K253023), a second-generation PET/MR platform cleared in January 2026 the most recent filing in the category and Siemens' first ground-up PET/MR refresh since the original Biograph mMR fourteen years earlier.

Shanghai United Imaging Healthcare holds four clearances, all under the same device name, uPMR 790, filed in February 2019, November 2019, November 2022, and May 2024, a cadence suggesting iterative updates to a single platform rather than a new product line each time. GE Medical Systems (doing business as GE HealthCare) holds three clearances for its SIGNA PET/MR system, filed in November 2014, February 2017, and January 2022. Philips Healthcare (Cleveland) holds a single clearance, the Ingenuity TF PET/MR (K103483), cleared in November 2011 alongside Siemens' original Biograph mMR and not updated in the FDA's OUO record since.

Global Hybrid PET MRI Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global hybrid PET MRI systems market report based on type, application, end-use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Traditional PET-MRI systems
• Helium-free PET-MRI systems
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Oncology
• Neurology
• Cardiovascular
• Musculoskeletal
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Diagnostic Imaging Centers
• Ambulatory Surgery Centers
• Specialty Clinics & Cath Labs
• Academic & Research Institutes
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Hybrid PET MRI Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Hybrid PET MRI Systems Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Hybrid PET MRI Systems Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Hybrid PET MRI Systems Market: Type Movement Analysis
• 4.3. Hybrid PET MRI Systems Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Traditional PET-MRI systems
  • 4.5.1. Traditional PET-MRI systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Helium-free PET-MRI systems
  • 4.6.1. Helium-free PET-MRI systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Hybrid PET MRI Systems Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Hybrid PET MRI Systems Market: Application Movement Analysis
• 5.3. Hybrid PET MRI Systems Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Oncology
  • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Neurology
  • 5.6.1. Neurology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Cardiovascular
  • 5.7.1. Cardiovascular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Musculoskeletal
  • 5.8.1. Musculoskeletal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Hybrid PET MRI Systems Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Hybrid PET MRI Systems Market: End use Movement Analysis
• 6.3. Hybrid PET MRI Systems Market by End use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Diagnostic Imaging Centers
  • 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Ambulatory Surgery Centers
  • 6.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Specialty Clinics & Cath Labs
  • 6.8.1. Specialty Clinics & Cath Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Academic & Research Institutes
  • 6.9.1. Academic & Research InstitutesMarket Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Hybrid PET MRI Systems Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Hybrid PET MRI Systems Market Movement Analysis
• 7.3. Hybrid PET MRI Systems Market: Regional Estimates & Trend Analysis
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Hybrid PET MRI Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Siemens Healthineers
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. GE HealthCare
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Koninklijke Philips N.V.
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. United Imaging Healthcare
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Bruker Corporation
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. Mediso Ltd.
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. MR Solutions
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Canon Medical Systems Corporation
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Cubresa Inc.
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Molecubes
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives